May. 29 at 8:35 PM
$LFST
LifeStance Health is delivering strong, profitable growth in outpatient mental health.
Q1 2026 Highlights
Revenue
$403.5M (+21% YoY)
Adj. EBITDA
$51.1M (+48%)
Net income turned positive at
$14.2M
2026 Guidance (Raised)
Revenue
$1.64–1.68B (~17% growth)
Adj. EBITDA
$200–220M
Outlook
Analysts forecast 13–15% annual revenue growth and 50% EPS growth. Margin expansion continues toward mid-teens.
Valuation
$7.80/share. Consensus Buy with average target
$9.86–10.72 (27–37%+ upside).
Bottom Line
Attractive growth story with accelerating profitability and meaningful analyst upside.